<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Wolfson Centre for Age Related Diseases</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/9CA51D73-CFF2-4FFA-864E-8312E85714E3"><gtr:id>9CA51D73-CFF2-4FFA-864E-8312E85714E3</gtr:id><gtr:firstName>Lawrence</gtr:firstName><gtr:otherNames>David</gtr:otherNames><gtr:surname>Moon</gtr:surname><gtr:orcidId>0000-0001-9622-0312</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0600998"><gtr:id>C97FBD2D-DA27-4DA8-B254-C96416CC291B</gtr:id><gtr:title>Enhancing axon growth and functional recovery after cerebral ischemia (stroke)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600998</gtr:grantReference><gtr:abstractText>Abnormal blood flow to one side of the brain (due to clots or bleeds) is called stroke and often causes disability in the opposite side of the body. Therapies need to work when given many hours after injury, because there is typically a delay to admission to hospital and diagnosis. Stroke primarily affects elderly people, yet few studies have examined potential therapies for stroke in an aged model system. Encouragingly, recent research shows that even aged brains and spinal cords have some capacity for adapting to stroke. There are, however, no restorative therapies for stroke. 
 We have previously shown that a drug, called chondroitinase ABC, can boost growth of injured nerve fibers and can restore function lost after spinal cord injury in adult rats. To date, the potential of chondroitinase ABC for promoting neural and functional recovery after stroke has not been examined. We propose investigating this here.
 Our study aims to overcome stroke-induced disabilities in limb function by encouraging compensation by spared (uninjured) nerve fibers of the brain and spinal cord. To simulate stroke in elderly people, a small stroke will be induced in the brain of anaesthetised elderly rats. Post-operative analgesia will be given. Combination therapy will be initiated one week later. To boost growth of nerve fibers from the opposite (uninjured) side of the brain, chondroitinase ABC will be injected into regions in the brain and spinal cord. Rats will be housed in environments known to encourage rehabilitation of the injured forepaw. Other rats will be used as controls in order to determine the effect of each part of the combination therapy. Rats will be tested weekly to assess recovery in rats treated with the therapies. After five weeks, tract tracing will be performed to determine whether uninjured nerve fibres have responded to treatment. Two weeks later, rats will be terminally anaesthetised to provide tissue for analysis. We will seek evidence that the combination therapy induced changes in nerve fiber connections that might explain any behavioural improvements observed.
 Results will be communicated to the general public after any publication embargo is lifted via press release sanctioned by our public relations department. We will also contact science reporters at national newspapers as well as magazines including New Scientist. I also participate in outreach to inner city schools, discussing risk factors for stroke, work involving responsible use of animals and potential therapies for stroke.</gtr:abstractText><gtr:technicalSummary>There is no fully restorative treatment for cerebral ischemia (stroke). Stroke primarily affects elderly people, yet relatively few studies have examined potential therapies for stroke in an aged model system. The aged central nervous system (CNS) is considered less capable of adaptive change than the young CNS, yet recent research supports the idea that even aged brains have potential for adaptation after injury. Environmental enrichment, cognitive challenge and locomotor rehabilitation can promote some recovery of function, but further advances are required. We have previously shown that CNS axon growth is restricted by the presence of growth inhibitory molecules including chondroitin sulphate. We have also shown that degradation of chondroitin sulphate using an enzyme (chondroitinase ABC) promotes axon regeneration and enhances functional recovery after penetrating injury to the brain or spinal cord. To date, the potential of chondroitinase ABC for promoting neural and functional recovery after stroke has not been examined.
The present study aims to enhance recovery of limb function in a model of unilateral focal cerebral ischemia (stroke) using aged rats by evaluating the effects of a delayed treatment intervention consisting of the enzyme (chondroitinase ABC), limb rehabilitation and environmental enrichment. A battery of behavioural tests and tract tracing will be used to assess recovery of limb function and axon growth, respectively.</gtr:technicalSummary><gtr:fund><gtr:end>2010-06-10</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-06-11</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>363509</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit, London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>42B295F8-CFA1-4CD4-B744-FD24EF503D83</gtr:id><gtr:impact>As part of my RCUK fellowship I conduct outreach many times each year.

One schools student was motivated to apply to my University (and was accepted) after listening to my talk on CNS injury research.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Schools visits to KCL</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>35B12ED9-6688-405A-B1ED-E024983409C4</gtr:id><gtr:impact>About 8 x 25 students (200) visited KCL for a range of talks including mine on stroke.

We were oversubscribed and offered a second day of talks. There is real appetite for these meetings during STEM week.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2323</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC ISIS</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>6AD8A7D1-472C-409B-90FE-54D795E19B1A</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>98000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>International Spinal Research Trust</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>International Spinal Research Trust (Spinal Research)</gtr:fundingOrg><gtr:id>BD835DDC-AD24-4E31-ACB2-063EEADC9491</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Henry Smith Charity</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>The Henry Smith Charity</gtr:fundingOrg><gtr:id>61B933F1-3C5E-4F91-86F6-5834952921AA</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>7000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>University of London Central Research Fund</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>King's College London (KCL)</gtr:fundingOrg><gtr:id>926DC4D5-69E9-4824-9DEB-A96E4FCB1E58</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>84350</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC PhD Studentship</gtr:description><gtr:end>2011-10-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>3E2B7FC7-96D8-4839-832D-8CEBAA92A52D</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Society</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>1213C4D9-7525-4121-866F-02090A2FCB7D</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1500000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>European Research Council Starter/Consolidator Grant</gtr:description><gtr:end>2017-11-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:id>71C9436F-3A8F-4304-855D-AF2FFE09E60C</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2012-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>8000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>2438A1A7-A2AA-4DBC-AE8C-E4F8352EB500</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Henry Smith Charity</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>The Henry Smith Charity</gtr:fundingOrg><gtr:id>92C2544C-48AD-4D1C-8200-6472806EAC84</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>63350</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Serendipity Award</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>The Dunhill Medical Trust</gtr:fundingOrg><gtr:id>41191C6C-6C09-405B-870A-657C52E93D19</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Our data was included in an application to the USA for a patent for the use of chondroitinase ABC as a therapy for CNS injury. This patent is not in my name but is in the name of my former PhD supervisor and others here at King's College London</gtr:description><gtr:id>864E7ECA-EBEE-4797-B6C7-5AFA5DD5AABA</gtr:id><gtr:impact>None yet</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:patentId>US2005118157</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Chondroitinase ABC as a therapy for stroke</gtr:title><gtr:yearProtectionGranted>2006</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>I am an invited member of the Working Group on Experimental Design for in vivo experiments convened by the National Centre for the 3Rs</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>351A1E5B-478E-4260-AAF9-975B1EC2965B</gtr:id><gtr:type>Membership of a guidance committee</gtr:type><gtr:url>https://eda.nc3rs.org.uk/eda/termsAndConditions/index</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Working group on Stroke convened by the NC3Rs</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BF307181-EA76-4A65-A723-1844DF81ABAB</gtr:id><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Steering Committee for Understanding Animals in Research</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1BFFFC0E-94A9-4F16-B703-6E89FB278A96</gtr:id><gtr:type>Participation in a national consultation</gtr:type><gtr:url>http://www.understandinganimalresearch.org.uk/policy/concordat-on-openness-on-animal-research</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>We have shown that intraspinal injection of chondroitinase ABC three days after stroke in an elderly rat modestly improves forelimb and hindlimb sensorimotor functions.</gtr:description><gtr:id>B32E4530-6B53-4628-A941-2B9B157E75A9</gtr:id><gtr:impact>None yet.</gtr:impact><gtr:stage>Initial development</gtr:stage><gtr:status>On hold</gtr:status><gtr:title>Chondroitinase ABC</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2011</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have written a how-to guide for other scientists to analyse data from longitudinal animal experiments, where some data are missing (e.g., due to drop-out). This guide is pending publication in Nature Protocols.</gtr:description><gtr:id>6B6EE392-E6C9-458D-A741-0E27FA314D51</gtr:id><gtr:impact>We have disseminated this protocol at various meetings and people have shown great interest in using these methods on their own datasets.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Protocol for analysis of longitudinal (repeated measures) in vivo data where some data are missing</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A model of unilateral focal cortical stroke in aged rats. Behavioural and histological assessment.</gtr:description><gtr:id>E4794180-A164-4C9F-8BCF-FE9DDDA01BD7</gtr:id><gtr:impact>We have used this model to evaluate two different potential therapies for stroke in an elderly nervous system. Both of these therapies provide a modest level of improvement.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Model of focal stroke in aged rats</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1A13268C-D08A-4570-919D-FB3A5831A4AE"><gtr:id>1A13268C-D08A-4570-919D-FB3A5831A4AE</gtr:id><gtr:title>Analysis of longitudinal data from animals with missing values using SPSS.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b8d838ca74985e78c6be618b6c112bb5"><gtr:id>b8d838ca74985e78c6be618b6c112bb5</gtr:id><gtr:otherNames>Duricki DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D42D7B29-7C91-4285-9BE0-750FA0DF2E29"><gtr:id>D42D7B29-7C91-4285-9BE0-750FA0DF2E29</gtr:id><gtr:title>Transcriptional changes in sensory ganglia associated with primary afferent axon collateral sprouting in spared dermatome model.</gtr:title><gtr:parentPublicationTitle>Genomics data</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2b538aac69112a6caf2998385bd85c28"><gtr:id>2b538aac69112a6caf2998385bd85c28</gtr:id><gtr:otherNames>Harrison BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-5960</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/75D05A58-4D4C-42EB-A05E-950791DE4D90"><gtr:id>75D05A58-4D4C-42EB-A05E-950791DE4D90</gtr:id><gtr:title>Delayed intramuscular human neurotrophin-3 improves recovery in adult and elderly rats after stroke.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b8d838ca74985e78c6be618b6c112bb5"><gtr:id>b8d838ca74985e78c6be618b6c112bb5</gtr:id><gtr:otherNames>Duricki DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/434C6165-A098-419A-AC4C-276FCF60B426"><gtr:id>434C6165-A098-419A-AC4C-276FCF60B426</gtr:id><gtr:title>Analysis of longitudinal data from animals using linear models in SPSS</gtr:title><gtr:parentPublicationTitle>Nature Protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1ad504b0ecd9ac5d309d2bf02d10c31e"><gtr:id>1ad504b0ecd9ac5d309d2bf02d10c31e</gtr:id><gtr:otherNames>Duricki D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C4B9BD7F-F9B2-44E6-BD5A-F73A7F8D04F1"><gtr:id>C4B9BD7F-F9B2-44E6-BD5A-F73A7F8D04F1</gtr:id><gtr:title>Sustained sensorimotor impairments after endothelin-1 induced focal cerebral ischemia (stroke) in aged rats.</gtr:title><gtr:parentPublicationTitle>Experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b9f7221e152e293e78328c5ed14e580b"><gtr:id>b9f7221e152e293e78328c5ed14e580b</gtr:id><gtr:otherNames>Soleman S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-4886</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CB9CDF9E-4500-43FE-AAB7-2AA89A2F6E5E"><gtr:id>CB9CDF9E-4500-43FE-AAB7-2AA89A2F6E5E</gtr:id><gtr:title>Corticospinal tract transduction: a comparison of seven adeno-associated viral vector serotypes and a non-integrating lentiviral vector.</gtr:title><gtr:parentPublicationTitle>Gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c0b063bbaf79ca8fb5ce0db482275651"><gtr:id>c0b063bbaf79ca8fb5ce0db482275651</gtr:id><gtr:otherNames>Hutson TH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0969-7128</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DB4BFDF2-3BD1-4003-854E-6436796DB31A"><gtr:id>DB4BFDF2-3BD1-4003-854E-6436796DB31A</gtr:id><gtr:title>Delayed treatment with chondroitinase ABC promotes sensorimotor recovery and plasticity after stroke in aged rats.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b9f7221e152e293e78328c5ed14e580b"><gtr:id>b9f7221e152e293e78328c5ed14e580b</gtr:id><gtr:otherNames>Soleman S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600998</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>